Article
Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine.
The Journal of infectious diseases - 1 May 1996
Zheng N N, McQueen P W, Hurren L, Evans L A, Law M G, Forde S, Barker S, Cooper D A, Delaney S F
Abstract excerpt
Progression to AIDS in patients harboring human immunodeficiency virus type-1 (HIV-1) isolates expressing a syncytium-inducing (SI) phenotype is faster than in those in whom the virus expresses a non-SI (NSI) phenotype. Zidovudine monotherapy does not appear to alter this outcome. To examine the...
Topics
- Antiviral Agents
- CD4 Lymphocyte Count
- Didanosine
- Disease Progression
- Double-Blind Method
- Giant Cells
- HIV Infections
- HIV-1
- Humans
- Leukocytes, Mononuclear
- Phenotype